Events & Presentations

Financial Third Quarter 2013 Results Conference Call

Kamada management will host an investment community conference call on Tuesday, October 29, 2013 beginning at 8:30 a.m. Eastern time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (from within the U.S.) or 706-634-5454 (from outside the U.S.) or 1-809-315-362 (toll-free from Israel) and entering passcode 87555865. The call also will be broadcast live on the Internet at www.streetevents.com, www.earnings.com and www.kamada.com. A replay of the conference call will be accessible two hours after its completion through November 4, 2013 by dialing (855) 859-2056 (from within the U.S.) or (404) 537-3406 (from outside the U.S.) and entering passcode 87555865. The call will also be archived for 90 days at www.streetevents.com, www.earnings.com and www.kamada.com.

Kamada to participate at the ERS annual congress

Kamada will host an investment community conference call

Kamada management will host an investment community conference call on 1.8.2013, beginning at 10:00 a.m. Eastern time to discuss Q2 results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing (888) 803-5993 (from within the U.S.) or (706) 634-5454 (from outside the U.S.) and entering passcode 21054403. The call also will be broadcast live on the Internet at www.streetevents.com, www.earnings.com and www.kamada.com.

Kamada to participate at the PPTA’s 2013 Plasma Protein Forum

People worldwide rely on access to plasma-derived and recombinant analog therapies to improve and save their lives, and this is an opportunity for all stakeholders to come together. Consumers, physicians, caregivers, regulators and policymakers, and industry representatives should attend. Key issues facing the industry today and in the future will be presented.

Kamada to speak at the 2013 IATI- Biomed confrence in Israel

IATI BIOMED 2013 follows the success of previous annual conferences where the Israeli Life Sciences industry hosted 6,000 industry players, engineers and scientists with approximately 1,000 participants from over 40 countries and in excess of 3,500 one-on-one meetings. Kamada's presentation, on new clinical developments for Alpha-1 Antitrypsin, will take place at June 10, 4:50pm.

Kamada to participate at the 22nd Alpha-1 patients national education conference in Washington

The National Conference is the largest gathering of Alphas and families in the world, with an expected attendance of more than 600 people,

Kamada to participate at the American Thoracic Society International Conference

The annual International Conference of the American Thoracic Society is one of the largest gatherings of pulmonary, critical care and sleep clinicians and researchers in the world.

Kamada to participate at the International Plasma Protein Congress (IPPC)

IPPC is the primary international congress for all stakeholders of plasma protein therapies. Sessions will feature topics such as clinical developments, patient access, self-sufficiency, regulatory considerations, plasma collection, health policy and much more.

Kamada to participate at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris

ATTD 2013 is an innovative conference that will bring together the world's leading researchers and clinicians for a lively exchange of ideas and information related to the treatment and prevention of diabetes and related illnesses.

Kamada to receive the Title of Outstanding Exporter from Israel’s President, Shimon Peres

The Israeli President will presents the outstanding exporter award to Kamada on its performance in 2011.